European Archives - Page 767 of 1346 - European Medical Journal

Respiratory Content Image

Tracheal Stenosis: One Region Experience

Tracheal stenosis (TS) after long-term artificial lung ventilation remains a problem in the Russian region. In the Urals region during…

Respiratory Content Image

Digital Support for Wheeze Detection in Young Children

Wheeze is difficult to describe and recognise, and there is a need for clear guidelines on diagnosing wheeze. Discrepancy exists between…

Respiratory Content Image

Skeletal Muscle Afferent Sensitivity in Interstitial Lung Disease: An Interim Analysis

Dyspnoea and exercise intolerance are near universal symptoms in fibrotic interstitial lung disease (fILD).1 Neither anti-fibrotic agents…

Respiratory Content Image

Improving Asthma and Chronic Obstructive Pulmonary Disease Outcomes in 2021: Approaches to Empower Patients

This symposium took place during the 2021 virtual meeting of the European Respiratory Society (ERS). It focused on improving the…

Respiratory Content Image

Latest ERS Guidelines on non-CPAP Therapies in Obstructive Sleep Apnoea

During the European Respiratory Society (ERS) International Congress 2021, speakers discussed the latest updates to the ERS…

Respiratory Content Image

Pneumomediastinum as a Complication of COVID-19 Pneumonia: A Self-Experience Study

Pneumomediastinum (PM) is a rare pathological entity that is divided into two categories: secondary, with a well-known aetiology, and…

Interview: Sarah Walmsley

As a medical student in Edinburgh, I was inspired by the opportunities in Edinburgh to combine clinical and basic science research in respiratory medicine.

Interview: Andres Floto

I have always been incredibly interested in science and in trying to understand how things work. My first degree was in natural sciences at Cambridge, UK, where I specialised in neurobiology, and this exposed me to the beauty and rigor of basic science.

Respiratory Content Image

Pulmonary Embolism in Vaccine-Induced Thrombotic Thrombocytopenia: Under-reported?

Vaccination is currently the most powerful tool for controlling the COVID-19 pandemic.1 In large randomised controlled trials, the approved vaccines have shown good efficacy and safety.2 However, there is increasing concern about the safety of the adenovirus-based COVID-19 vaccines of AstraZeneca (ChAdOx1 nCoV-19) and Janssen (Ad26.COV2.S).

Respiratory Content Image

Stroke in a Patient with Recurrent Meningeal Tuberculosis and HIV Coinfection

The World Health Organization (WHO) has reported that an estimated 10.0 million people (range: 8.9–11.0 million) became ill with tuberculosis (TB) in 2019. There were an estimated 1.2 million TB deaths (range: 1.1–1.3 million) among people who were HIV-negative in 2019 and an additional 208,000 deaths (range: 177,000–242,000) among people who were HIV-positive.